WallStSmart

Salesforce.com Inc (CRM)vsHealth In Tech, Inc. Class A Common Stock (HIT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 135057% more annual revenue ($41.52B vs $30.72M). CRM leads profitability with a 18.0% profit margin vs 4.7%. CRM trades at a lower P/E of 23.5x. CRM earns a higher WallStSmart Score of 63/100 (C+).

CRM

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 7.0Value: 10.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.83

HIT

Hold

39

out of 100

Grade: F

Growth: 8.7Profit: 5.5Value: 3.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRMUndervalued (+34.2%)

Margin of Safety

+34.2%

Fair Value

$276.43

Current Price

$181.96

$94.47 discount

UndervaluedFair: $276.43Overvalued
HITSignificantly Overvalued (-129.8%)

Margin of Safety

-129.8%

Fair Value

$0.47

Current Price

$1.81

$1.34 premium

UndervaluedFair: $0.47Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRM4 strengths · Avg: 8.5/10
Market CapQuality
$171.49B9/10

Large-cap with strong market position

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$5.32B8/10

Generating 5.3B in free cash flow

HIT1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
90.4%10/10

Revenue surging 90.4% year-over-year

Areas to Watch

CRM1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.834/10

Grey zone — moderate risk

HIT4 concerns · Avg: 2.5/10
Market CapQuality
$102.44M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

P/E RatioValuation
90.0x2/10

Premium valuation, high expectations priced in

Free Cash FlowQuality
$-939,3992/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : CRM

The strongest argument for CRM centers on Market Cap, Debt/Equity, Price/Book. Profitability is solid with margins at 18.0% and operating margin at 19.2%. Revenue growth of 12.1% demonstrates continued momentum.

Bull Case : HIT

The strongest argument for HIT centers on Revenue Growth. Revenue growth of 90.4% demonstrates continued momentum.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score.

Bear Case : HIT

The primary concerns for HIT are Market Cap, Profit Margin, P/E Ratio. A P/E of 90.0x leaves little room for execution misses. Thin 4.7% margins leave little buffer for downturns.

Key Dynamics to Monitor

CRM profiles as a mature stock while HIT is a hypergrowth play — different risk/reward profiles.

HIT is growing revenue faster at 90.4% — sustainability is the question.

CRM generates stronger free cash flow (5.3B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRM scores higher overall (63/100 vs 39/100), backed by strong 18.0% margins and 12.1% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Health In Tech, Inc. Class A Common Stock

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Health In Tech, Inc. (HIT) is a pioneering force in the convergence of healthcare and technology, committed to revolutionizing care delivery through cutting-edge digital solutions. Leveraging advanced data analytics and proprietary software, HIT enhances decision-making capabilities for healthcare providers and patients alike, thereby elevating patient outcomes and operational efficiencies. With a strong emphasis on compliance and cybersecurity, the company is strategically positioned to capitalize on the burgeoning growth of the digital health market. As the demand for innovative, technology-driven healthcare solutions accelerates, HIT is well-equipped to emerge as a leading player in this transformative landscape.

Want to dig deeper into these stocks?